Septerna, Inc. SEPN 深 滬
等待開盤 10-23 09:30:00 美东时间
22.00
+0.690
+3.24%
華盛通- 最 高22.20
- 今 開21.27
- 成交量 40.45万股
- 最 低 20.8167
- 昨 收 21.31
- 總市值 9.80亿
- 52周最高 28.99
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 4.17
- 委 比 -85.32%
- 總股本 4455.83万
- 歷史最高 28.99
- 量 比 1.43
- 振 幅 6.49%
- 歷史最低 4.17
- 每 手 1
- 風險率 6.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Septerna, Inc. Expands Board with New R&D Chair
An update from Septerna, Inc. ( ($SEPN) ) is now available. On September 25, 20...
09-30 05:00
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
<p align="left">Septerna, Inc. has appointed Dr. Keith Gottesdiener to its board of directors, where he will chair a newly created R&D Committee. Dr. Gottesdiener, with over 30 years of experience in advancing medicines from discovery to commercialization, brings valuable expertise in regulatory strategy and clinical development. His leadership is expected to support Septerna's efforts in advancing its GPCR-targeted therapies, particularly its PT...
09-29 20:01
MBX surges 160% on mid-stage data for hypoparathyroidism drug canvuparatide
MBX Biosciences (NASDAQ:MBX) is up ~160% in Monday morning trading after posting phase 2 data on hypoparathyroidism candidate canvuparatide indicating it met its primary goal. In the 12-week randomize...
09-22 22:20
减肥药巨头中场战事，国产GLP-1「围剿」司美
原标题：减肥药巨头中场战事，国产GLP-1「围剿」司美 新官上任三把火。在履新诺和诺德（NVO.US）CEO一个月后，马齐亚尔·迈克·杜斯特达（Maziar...
09-15 16:32
SA Asks: Which biotechs could be acquired by year's end?
The fourth quarter has historically been a busy time for the biopharma industry, with the sector generally seeing a significant uptick in M&A activity. We asked Seeking Alpha analysts Stephen Ayers ...
09-14 04:18
Cantor Fitzgerald Reiterates Overweight on Septerna, Maintains $25 Price Target
Cantor Fitzgerald analyst Josh Schimmer reiterates Septerna (NASDAQ:SEPN) with a Overweight and maintains $25 price target.
09-05 21:52
美股牛股 | 绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%
绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%，美参议院议员敦促特朗普政府暂缓出售公司股份>>
09-04 17:12
诺和诺德扳回一局，称减重版司美格鲁肽心血管获益优于替尔泊肽
在GLP-1（胰高血糖素样肽-1）减肥药的竞争中，诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。 9月1日，澎湃新闻记者从诺和诺德中国获悉，该公司在西班...
09-01 14:32
Septerna to Participate in Upcoming Investor Conferences
Septerna, Inc., a clinical-stage biotech company focused on GPCR drug discovery, announced its participation in two upcoming investor conferences in September: the Cantor Global Healthcare Conference 2025 on September 3, 2025, and the 2025 Wells Fargo Healthcare Conference on September 5, 2025. Live webcasts and replays of the presentations will be available on the company’s website. Septerna specializes in advancing GPCR therapies using its prop...
08-27 12:00
Septerna Begins Phase 1 Trial for SEP-631
The latest announcement is out from Septerna, Inc. ( ($SEPN) ). On August 21, 2...
08-21 20:58
